Dose-escalation of filgrastim does not improve efficacy: clinical tolerability and long-term follow-up on CALGB study 9141 adjuvant chemotherapy for node-positive breast cancer patients using dose-intensified doxorubicin plus cyclophosphamide follow (Q37118467)
Jump to navigation
Jump to search
scientific article published on 30 January 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Dose-escalation of filgrastim does not improve efficacy: clinical tolerability and long-term follow-up on CALGB study 9141 adjuvant chemotherapy for node-positive breast cancer patients using dose-intensified doxorubicin plus cyclophosphamide follow |
scientific article published on 30 January 2008 |
Statements
1 reference
Dose-escalation of filgrastim does not improve efficacy: clinical tolerability and long-term follow-up on CALGB study 9141 adjuvant chemotherapy for node-positive breast cancer patients using dose-intensified doxorubicin plus cyclophosphamide follow (English)
1 reference
Cancer and Leukemia Group B
1 reference
Gloria Broadwater
1 reference
Minetta C Liu
1 reference
Eric P Winer
1 reference
Nancy Lin
1 reference
Jerry Younger
1 reference
Clifford A Hudis
1 reference
George D Demetri
1 reference
Donald A Berry
1 reference
Nicholas J Robert
1 reference
David Duggan
1 reference
Daniel F Hayes
1 reference
I Craig Henderson
1 reference
Alan Lyss
1 reference
Judith Hopkins
1 reference
Peter A Kaufman
1 reference
P Kelly Marcom
1 reference
Katherine Tkaczuk
1 reference
30 January 2008
1 reference
1 reference
223-230
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference